Disorders of lipid metabolism, such as obesity and nonalcoholic fatty liver disease, can lead to abnormal elevation of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The gene discussed is GPT; the disease is obesity disorder.